VISTAGEN THERAPEUTICS, INC. Cash
VISTAGEN THERAPEUTICS, INC. (VTGN) had Cash of $13.20 thousand as of 2014-12-31, per its 10-Q filed 2015-02-17.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:Cash · last filed 2015-02-17
- 2014-12-31: Cash $13.20K.
- 2014-06-30: Cash $400.70K.
| Period end | Cash |
|---|---|
| 2014-12-31 | $13.20K 10-Q · filed 2015-02-17 |
| 2014-06-30 | $400.70K 10-Q · filed 2014-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |